Trade AstraZeneca ^AZN

China charges former AstraZeneca executive - what it means for global pharmaceutical firms | South China Morning Post

Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine | Morningstar

Prices, pipelines and patent cliffs: Inside pharma's big reset

AstraZeneca Earnings: Strong Finish to Year, and Busy Schedule of Data Readouts Ahead | Morningstar UK

AstraZeneca PLC (LON:AZN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Genome-wide association analyses highlight the role of the intestinal molecular environment in human gut microbiota variation

AstraZeneca's Portfolio and Pipeline Support Solid Long-Term Growth | Morningstar

Here's What Lifted AstraZeneca PLC (AZN) in Q4

6,649 Shares in AstraZeneca PLC $AZN Acquired by Westover Capital Advisors LLC

Madison Asset Management LLC Trims Stock Holdings in AstraZeneca PLC $AZN

AstraZeneca PLC (AZN) to Issue Dividend of 1.60 on March 23rd - Stock Observer

Q3 Results 12th Feb Live: Hindustan Unilever, ONGC, Hindustan Aeronautics, Coal India, Hindalco, 3M India, Abbott India, Muthoot Finance, Lupin, Indian Hotels, Bharat Forge, IRCTC to announce Q3 results, Ashok Leyland, M&M, Lenskart, Divi's Lab, Godrej, Patanjali, AstraZeneca shares in focus

Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphoma

A Tragedy of Early COVID Has Finally Been Explained - The Atlantic

Why eight Australians died after having AstraZeneca's COVID vaccine

AstraZeneca (LON:AZN) Hits New 12-Month High - Still a Buy? - Markets Daily

Citi maintains 'buy' on AstraZeneca with £170 target, cites sector-best pipeline

AstraZeneca PLC (NASDAQ:AZN) Plans Dividend of 1.60 - Markets Daily

AstraZeneca PLC $AZN Holdings Boosted by ABC Arbitrage SA

Inherited risk of coronary artery disease: redefining care with imaging and genetics

China charges former AstraZeneca regional head Leon Wang a year after detaining him. Here's why

Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China | Morningstar

AstraZeneca Q4 Earnings Call Highlights | MarketBeat

Jim Cramer on DuPont's Lori Koch: "She's Done a Terrific Job" - Insider Monkey

Jim Cramer on Coca-Cola's Retiring CEO: "He Will Be missed"

Jim Cramer Says "The Street Has Decided That S&P Global Isn't Worth as Much as We Thought" - Insider Monkey

Jim Cramer on AstraZeneca: "We Want Every Drug Stock"

Jim Cramer on CVS: "I Think It's a Fascinating Time to Own the Stock" - Insider Monkey

AstraZeneca Q4 Earnings Call Highlights - Stock Observer

Stock Market Today, Feb: 10: Stocks are flat after retail sales are unchanged in December

AstraZeneca PLC $AZN Shares Sold by Foresight Group Ltd Liability Partnership

Oppenheimer Asset Management Inc. Increases Position in AstraZeneca PLC $AZN

ProShare Advisors LLC Has $50.24 Million Stock Holdings in AstraZeneca PLC $AZN - Markets Daily

AstraZeneca (NASDAQ:AZN) Sets New 1-Year High - What's Next? - Stock Observer

AstraZeneca CFO: 2025 was an amazing year

AstraZeneca's growth engine stays on track despite cost pressures

AstraZeneca CEO teases weight-loss drug candidate as profit meets target | Morningstar

AstraZeneca forecasts growth in 2026 as it builds drug pipeline - The Business Times

AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication - The Economic Times

LONDON BRIEFING: BP halts buybacks; AstraZeneca lifts annual earnings

AstraZeneca closes 2025 with strong financials and impressive product range

AstraZeneca profit climbs on cancer and heart drug demand | Morningstar

AstraZeneca profit jumps as cancer drug sales grow - Latest News

Relaxin unrest after Astrazeneca phase II HF bid joins failures | BioWorld

Identifying 3D signal overlaps in spatial transcriptomics data with ovrlpy

AstraZeneca share price rises on back of latest results

Smartleaf Asset Management LLC Buys 9,366 Shares of AstraZeneca PLC $AZN

Week Ahead: Tech Volatility Clouds Market Ahead of Jobs, CPI, Retail Data | Investing.com NG

AstraZeneca News | Markets Insider

Jones Financial Companies Lllp Buys 13,964 Shares of AstraZeneca PLC $AZN

Jones Financial Companies Lllp Increases Stock Holdings in AstraZeneca PLC $AZN - Stock Observer

a16z Perennial Management L.P. Takes $306,000 Position in AstraZeneca PLC $AZN - Markets Daily

AstraZeneca Oncology Advances Raise Questions On Valuation And Future Growth

Constitutional BRCA1 Methylation is associated with high level of tumoral BRCA1 methylation and homologous recombination deficiency in triple-negative breast cancer

AstraZeneca price target raised to 11,500 GBp from 11,000 GBp at Deutsche Bank | Markets Insider

Stocks to watch next week: BP, Barclays, AstraZeneca, Airbnb and Coinbase

8,164 Shares in AstraZeneca PLC $AZN Acquired by ABN AMRO Bank N.V.

US takes aim at Chinese minerals control

Hantz Financial Services Inc. Purchases 22,427 Shares of AstraZeneca PLC $AZN - Markets Daily

AstraZeneca's Imfinzi Combo Receives CDSCO Approval for Gastric Cancer Treatment, ETPharma

SpaceX's $1.2 Trillion IPO Tempts Chinese Investors With Anticipation Of Foreign Influence

AstraZeneca CEO: China set to become major global engine of innovation - Chinadaily.com.cn

AstraZeneca CEO: China at heart of global biotech innovation, 100b yuan investment by company to deepen global cooperation - Chinadaily.com.cn

Triglav Investments D.O.O. Has $7.69 Million Position in AstraZeneca PLC $AZN - Daily Political

AstraZeneca (NASDAQ:AZN) Reaches New 1-Year High - Time to Buy? - Markets Daily

Cambridge A-Listers Arm and AstraZeneca see stock rise in US

Callan Family Office LLC Has $3.27 Million Stock Position in AstraZeneca PLC $AZN - Markets Daily

AstraZeneca partners with Chinese firm ahead of next obesity race

Is this FTSE 100 behemoth a no-brainer AI stock?

AstraZeneca PLC $AZN Stake Reduced by Callan Family Office LLC - Stock Observer

Exploring the Guangdong Capital Behind the Commercial Aerospace Six Big Players

Mapping Guangdong Capital Behind China's Aerospace Six Big Players

China's Dominance in Rare Earth Elements and Its Uncertain Future

China's Trade Surplus and Economic Challenges Ahead

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes

AstraZeneca rises 101.5% | Markets Insider

Jim Cramer Says "I Like AstraZeneca Very Much"

Walmart hits $1 trillion in market value for the first time

AZN: Oncology Pipeline And Manufacturing Investments Will Shape Balanced Long-Term Outlook

NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

WCM Investment Management LLC Buys 10,677 Shares of AstraZeneca PLC $AZN - Markets Daily

AstraZeneca PLC $AZN Shares Sold by Principal Financial Group Inc.

Beijing's Capital Controls Fuel Rise of USDT and Bitcoin Against Declining Renminbi in Global Reserves

AstraZeneca reports FDA issued CRL for BLA for subcutaneous Saphnelo | Markets Insider

AstraZeneca PLC (NASDAQ:AZN) Announces Strategic Collaboration Agreement With CSPC Pharmaceuticals

With 13% annual earnings growth forecast and 45% under 'fair value', should I buy more of this FTSE giant now?

AstraZeneca says FDA backs Datroway, seeks more assurance on Saphnelo

DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy | Morningstar

AstraZeneca PLC (LON:AZN) Receives £143.33 Consensus PT from Analysts - Stock Observer